Pulmonary toxicity in stage III non-small cell lung cancer patients treated with high dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: A secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105
      QxMD      Google Scholar   
Citation:
Int J Radiat Oncol Biol Phys vol 81 (4) e269-e274
Year:
2011
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
1
Parents:
599  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA047577, CA11789, U10 CA029511, CA02599, CA47577, U10 CA045808, CA03927, U10 CA031946, U10 CA033601, CA45808, CA12046, U10 CA033601-32, U10 CA045418, U10 CA029511-20, CA16450, U10 CA047559, CA47559, CA45418, CA37135, U10 CA031946-29, U10 CA003927  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
CALGB-30105
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Chemoradiotherapy, 3D Conformal Radiotherapy, Non-small cell lung cancer, pulmonary toxicity